Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Novartis and Novo helped provide $40m for the EPFL spinout that supported its acquisition of joint venture Kanyos Bio.

Annual turnover and invention disclosures at Satt Sud-Est fell as the TTO shifted its strategy in favour of deep tech applications and co-maturation agreements.

The immuno-oncology drug developer, spun out of Johannes Gutenberg University Mainz, has filed for a $100m offering in the US.

Praktikertjänst-backed Aprea Therapeutics has filed for a $68.3m initial public offering that will fund the clinical progress of its cancer drug candidates.

The immuno-oncology drug developer, which counts numerous pharmaceutical firms among its investors, has filed for a $100m offering in the US.

Smart industrial glove producer ProGlove has received $40m from Summit Partners that comes after two rounds featuring corporate venturer Intel Capital.

Karolinska Institute spinout Aprea Therapeutics has filed to raise approximately $68.3m in an IPO that will see it list on the Nasdaq Global Select Market.

Anglo American Platinum-backed investment fund AP Ventures has secured $30m from Compagnie Plastic Omnium for its AP Ventures Fund II fund.

Institut Mérieux has returned for a $26.5m round for surgical technology developer Keranova, having previously supported a $4.6m round three and a half years ago.